Table 2.
Model 1 | Model 2 | Model 3 | Model 4 | |||||
---|---|---|---|---|---|---|---|---|
B | SE | B | SE | B | SE | B | SE | |
Female | 0.022 | 0.099 | -0.013 | 0.098 | 0.032 | 0.099 | 0.060 | 0.100 |
BMI (kg/m2) | 0.039* | 0.016 | 0.043** | 0.015 | ||||
Symptoms of infection (0, 1) | 0.424** | 0.139 | 0.431** | 0.139 | ||||
Oral contraception (0, 1) | -1.102** | 0.396 | -1.148** | 0.394 | ||||
Constant | -1.414*** | 0.334 | -0.651*** | 0.069 | -0.593*** | 0.066 | -1.557*** | 0.334 |
Model p value | <0.05 | <0.01 | <0.05 | <0.001 |
p<0.10;
p<0.05;
p<0.01;
p<0.001
Note: Models 1-3 consider gender as well as the separate associations of adiposity (model 1), pathogen exposure (model 2), and health behavior variables (model 3) shown in bivariate analyses to predict IL-6 at p<0.10. Model 4 considers all variables simultaneously to evaluate their independence in predicting IL-6.